vs

Side-by-side financial comparison of NovoCure Ltd (NVCR) and Resolute Holdings Management, Inc. (RHLD). Click either name above to swap in a different company.

NovoCure Ltd is the larger business by last-quarter revenue ($174.1M vs $117.7M, roughly 1.5× Resolute Holdings Management, Inc.). Resolute Holdings Management, Inc. runs the higher net margin — -1.5% vs -40.9%, a 39.4% gap on every dollar of revenue.

NovoCure Ltd is a global oncology company that develops and commercializes innovative Tumor Treating Fields (TTFields) therapy, a non-invasive wearable treatment using low-intensity electric fields to disrupt cancer cell division. Its approved therapies target glioblastoma, malignant mesothelioma and non-small cell lung cancer, serving patients across North America, Europe and Asia Pacific.

Resolute Mining Limited is an Australian mining corporation focused on mining operations in Africa. It is currently operating two gold mines: the Syama Gold Mine in Mali and the Mako Gold Mine in Senegal.

NVCR vs RHLD — Head-to-Head

Bigger by revenue
NVCR
NVCR
1.5× larger
NVCR
$174.1M
$117.7M
RHLD
Higher net margin
RHLD
RHLD
39.4% more per $
RHLD
-1.5%
-40.9%
NVCR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
NVCR
NVCR
RHLD
RHLD
Revenue
$174.1M
$117.7M
Net Profit
$-71.1M
$-1.7M
Gross Margin
77.6%
55.7%
Operating Margin
30.2%
Net Margin
-40.9%
-1.5%
Revenue YoY
12.3%
Net Profit YoY
-107.3%
EPS (diluted)
$-0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NVCR
NVCR
RHLD
RHLD
Q1 26
$174.1M
Q4 25
$174.3M
$117.7M
Q3 25
$167.2M
$120.9M
Q2 25
$158.8M
$119.6M
Q1 25
$155.0M
$103.9M
Q4 24
$161.3M
Q3 24
$155.1M
Q2 24
$150.4M
Net Profit
NVCR
NVCR
RHLD
RHLD
Q1 26
$-71.1M
Q4 25
$-24.5M
$-1.7M
Q3 25
$-37.3M
$-231.0K
Q2 25
$-40.1M
$-611.0K
Q1 25
$-34.3M
$-3.4M
Q4 24
$-65.9M
Q3 24
$-30.6M
Q2 24
$-33.4M
Gross Margin
NVCR
NVCR
RHLD
RHLD
Q1 26
77.6%
Q4 25
75.8%
55.7%
Q3 25
73.2%
59.0%
Q2 25
73.9%
57.5%
Q1 25
75.1%
52.5%
Q4 24
79.2%
Q3 24
77.2%
Q2 24
77.0%
Operating Margin
NVCR
NVCR
RHLD
RHLD
Q1 26
Q4 25
-23.2%
30.2%
Q3 25
-21.5%
34.3%
Q2 25
-24.9%
34.0%
Q1 25
-24.4%
24.7%
Q4 24
-39.3%
Q3 24
-20.7%
Q2 24
-22.3%
Net Margin
NVCR
NVCR
RHLD
RHLD
Q1 26
-40.9%
Q4 25
-14.1%
-1.5%
Q3 25
-22.3%
-0.2%
Q2 25
-25.3%
-0.5%
Q1 25
-22.1%
-3.2%
Q4 24
-40.9%
Q3 24
-19.7%
Q2 24
-22.2%
EPS (diluted)
NVCR
NVCR
RHLD
RHLD
Q1 26
Q4 25
$-0.22
$-0.20
Q3 25
$-0.33
$-0.03
Q2 25
$-0.36
$-0.07
Q1 25
$-0.31
$-0.39
Q4 24
$-0.61
Q3 24
$-0.28
Q2 24
$-0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NVCR
NVCR
RHLD
RHLD
Cash + ST InvestmentsLiquidity on hand
$432.0M
$205.5M
Total DebtLower is stronger
$169.8M
Stockholders' EquityBook value
$330.7M
$6.5M
Total Assets
$787.9M
$333.4M
Debt / EquityLower = less leverage
26.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NVCR
NVCR
RHLD
RHLD
Q1 26
$432.0M
Q4 25
$93.5M
$205.5M
Q3 25
$342.1M
$148.0M
Q2 25
$149.6M
$99.9M
Q1 25
$127.3M
$71.0M
Q4 24
$163.8M
Q3 24
$185.4M
Q2 24
$164.8M
Total Debt
NVCR
NVCR
RHLD
RHLD
Q1 26
Q4 25
$169.8M
Q3 25
$173.4M
Q2 25
$177.1M
Q1 25
$180.7M
Q4 24
Q3 24
Q2 24
Stockholders' Equity
NVCR
NVCR
RHLD
RHLD
Q1 26
$330.7M
Q4 25
$340.5M
$6.5M
Q3 25
$341.3M
$10.8M
Q2 25
$349.4M
$9.6M
Q1 25
$362.0M
$8.9M
Q4 24
$360.2M
Q3 24
$360.8M
Q2 24
$361.8M
Total Assets
NVCR
NVCR
RHLD
RHLD
Q1 26
$787.9M
Q4 25
$804.3M
$333.4M
Q3 25
$1.4B
$293.2M
Q2 25
$1.2B
$253.3M
Q1 25
$1.2B
$214.3M
Q4 24
$1.2B
Q3 24
$1.2B
Q2 24
$1.2B
Debt / Equity
NVCR
NVCR
RHLD
RHLD
Q1 26
Q4 25
26.03×
Q3 25
16.01×
Q2 25
18.42×
Q1 25
20.38×
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NVCR
NVCR
RHLD
RHLD
Operating Cash FlowLast quarter
$196.1M
Free Cash FlowOCF − Capex
$189.2M
FCF MarginFCF / Revenue
160.8%
Capex IntensityCapex / Revenue
5.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$313.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NVCR
NVCR
RHLD
RHLD
Q1 26
Q4 25
$-18.0M
$196.1M
Q3 25
$20.6M
$59.6M
Q2 25
$-15.9M
$48.9M
Q1 25
$-35.7M
$18.4M
Q4 24
$-3.5M
Q3 24
$10.4M
Q2 24
$-1.7M
Free Cash Flow
NVCR
NVCR
RHLD
RHLD
Q1 26
Q4 25
$-22.9M
$189.2M
Q3 25
$14.9M
$58.6M
Q2 25
$-21.4M
$47.5M
Q1 25
$-46.3M
$17.8M
Q4 24
$-12.4M
Q3 24
$-307.0K
Q2 24
$-13.2M
FCF Margin
NVCR
NVCR
RHLD
RHLD
Q1 26
Q4 25
-13.1%
160.8%
Q3 25
8.9%
48.5%
Q2 25
-13.5%
39.7%
Q1 25
-29.9%
17.1%
Q4 24
-7.7%
Q3 24
-0.2%
Q2 24
-8.8%
Capex Intensity
NVCR
NVCR
RHLD
RHLD
Q1 26
Q4 25
2.8%
5.8%
Q3 25
3.4%
0.8%
Q2 25
3.5%
1.2%
Q1 25
6.8%
0.6%
Q4 24
5.5%
Q3 24
6.9%
Q2 24
7.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons